fda

Ebola Patient Who Received Aethlon (OTCBB: AEMD) Hemopurifier® Therapy Has Been Discharged From Hospital

Biodefense Breaking News: Ebola Patient Who Received Aethlon (OTCBB: AEMD) Hemopurifier® Therapy Has Been Discharged From HospitalSAN DIEGO – November 25, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that an Ebola patient who received Hemopurifier® therapy has been reported to have been discharged from Frankfurt […]

Top Medical Marijuana Stock

Headquartered in Salsbury, United Kingdom, GW Pharmaceuticals (NASDAQ:GWPH) uses its proprietary cannabinoid product platform to create and develop new therapeutics that can be used for a variety of treatments. The company’s therapeutics, along with current and proposed treatments, include:· Sativex® for treating chronic cancer pain and multiple sclerosis spasticity· Epidiolix® for the treatment of childhood epilepsy, Dravet syndrome, and Lennox-Gastaut […]

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's …

Geron Corporation (GERN – Analyst Report) was in the spotlight last week with the company striking a collaboration deal with Johnson & Johnson for its sole pipeline candidate, imetelstat. Meanwhile, companies like Gilead (GILD – Analyst Report) and Regeneron (REGN – Analyst Report) remained in the news thanks to regulatory updates.Recap of the Week’s Most Important Stories1. Geron, which had […]

Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on …

Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]

Stanford's big data conference: How 1s and 0s are advancing …

Saul BrombergerBioinformatics expert Atul Butte leads a panel discussion on the diverse sources of data at the Big Data in Biomedicine Conference on the Stanford campus.Massive, ongoing advances in computational processing power and interconnectedness are already changing the way medical research is done. But even more-disruptive outcomes — including changes in the very practice of medicine at the day-to-day clinical […]

The FDA Sets Its Sights on Social Media | HIStalk Connect

The Food and Drug Administration is soliciting bids for a contractor that will monitor social media and map out the peaks and troughs of drug and medical device risk-based chatter. The FDA is targeting blogs, forums, message boards, wikis, and podcasts as potential new opportunities to engage the public.The focus of the project will be to help the FDA evaluate […]

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential …

Often when a strong sell-off hits the stock market, the first stocks to go are the big momentum stocks that hedge funds often chase for performance and alpha. Right behind them you can often find the small-cap biotech stocks that have huge promise but do not fit well when there is a risk-off mentality. The recent sell-off, which totaled almost […]